News

Retinal neuroprostheses or `bionic eyes', aim to restore patterned vision to those with vision loss by electrically stimulating the remaining neurons in the degenerate retina. Despite considerable ...
Both 6-month trials were randomized, controlled studies that evaluated PER-001 delivered in a slow-release, dissolvable ...
Two examples of FDA-approved intracameral implants are Durysta (Allergan) and iDoseTR (Glaukos), both of which provide ...
Retinal prostheses are biomedical devices that directly utilize electrical stimulation to create an artificial vision to help patients with retinal diseases such as retinitis pigmentosa. A major ...
Neurotech company Paradromics achieved a milestone with the first human brain implant during epilepsy surgery, moving closer to clinical trials for patients with severe movement impairments.
Matt Angle, CEO of Paradromics, talks about the company's recent achievement of completing its first ever brain implant surgery on a human patient. Angle explains the opportunities to treat ...
Beijing has reported some experiments with implants by startup companies over the past months, but the clinical trial shows China is in a tight race with the US in developing this frontier technology.
--Aurora Spine Corporation, a leader in innovative spinal implant technology, is proud to announce that its DEXA-C™ system has now been successfully used in more than 1,500 cervical spine ...